| |
| |
|
| Insider
Information: |
Jorden David Emerson |
| Relationship: |
Acting Chief Financial... |
| City: |
The Woodlands |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
8,185,727 |
|
|
Indirect Shares
|
190 |
|
|
| Direct
Value |
$113,706,560 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
8,185,917 |
|
|
| Total
Value |
$113,706,560 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acer Therapeutics Inc |
ACER |
Director |
2013-09-24 |
293,456 |
|
0 |
Premium* |
|
|
Cytomedix Inc |
CMXI |
CEO/CFO, Director |
2022-11-09 |
1,975,358 |
2017-08-10 |
190 |
Premium* |
|
|
ConnectOne Bancorp, Inc |
CNOB |
Director, 10% Owner |
2011-03-09 |
5,765,000 |
2011-03-09 |
0 |
Premium* |
|
|
Plx Pharma Inc |
PLXP |
Acting Chief Financial... |
2017-06-14 |
151,913 |
2017-04-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CMXI |
Cytomedix Inc |
CEO/CFO |
• • – |
2022-11-09 |
4 |
S |
$1.50 |
$243,750 |
D/D |
(162,500) |
1,975,358 |
0 |
- |
|
| CMXI |
Cytomedix Inc |
CEO/CFO |
• • – |
2022-04-29 |
4 |
A |
$1.00 |
$10,532 |
D/D |
10,532 |
2,137,858 |
0 |
- |
|
| CMXI |
Cytomedix Inc |
CEO, CFO |
• • • |
2017-08-10 |
4 |
B |
$0.22 |
$54,995 |
D/D |
247,500 |
557,146 |
3.23 |
- |
|
| PLXP |
Plx Pharma Inc |
Acting Chief Financial Officer |
• – • |
2017-06-14 |
4 |
B |
$6.88 |
$224,998 |
D/D |
32,727 |
151,913 |
4.01 |
- |
|
| PLXP |
Plx Pharma Inc |
Acting Chief Financial Officer |
• – – |
2017-04-19 |
4 |
A |
$0.00 |
$0 |
D/D |
119,186 |
119,186 |
0 |
- |
|
| CMXI |
Cytomedix Inc |
CEO and CFO |
• • – |
2016-05-05 |
4 |
B |
$1.00 |
$137,500 |
D/D |
137,500 |
137,500 |
2.81 |
- |
|
| CMXI |
Cytomedix Inc |
CEO and CFO |
• • – |
2016-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
172,146 |
309,646 |
0 |
- |
|
| CMXI |
Cytomedix Inc |
CEO and CFO |
• • – |
2016-05-05 |
4 |
A |
$0.00 |
$0 |
I/I |
167 |
167 |
0 |
- |
|
| ACER |
Acer Therapeutics Inc |
Director |
– • – |
2013-09-24 |
4 |
OE |
$1.91 |
$118,252 |
D/D |
61,912 |
293,456 |
0 |
- |
|
| ACER |
Acer Therapeutics Inc |
Director |
– • – |
2013-06-30 |
4 |
A |
$1.54 |
$6,853 |
D/D |
4,450 |
231,544 |
0 |
- |
|
| CMXI |
Cytomedix Inc |
Director |
– • – |
2013-05-21 |
4 |
B |
$0.50 |
$27,500 |
D/D |
55,000 |
6,905,000 |
2.39 |
- |
|
| CMXI |
Cytomedix Inc |
Director |
– • – |
2013-05-17 |
4 |
B |
$0.50 |
$12,500 |
D/D |
25,000 |
6,850,000 |
2.39 |
- |
|
| CMXI |
Cytomedix Inc |
Director |
– • – |
2013-04-19 |
4 |
B |
$0.50 |
$7,500 |
D/D |
15,000 |
6,875,000 |
2.39 |
- |
|
| CMXI |
Cytomedix Inc |
Director |
– • – |
2013-04-18 |
4 |
B |
$0.51 |
$10,200 |
D/D |
20,000 |
6,860,000 |
2.39 |
- |
|
| CMXI |
Cytomedix Inc |
Director |
– • – |
2013-04-17 |
4 |
B |
$0.51 |
$7,650 |
D/D |
15,000 |
6,840,000 |
2.39 |
- |
|
| CMXI |
Cytomedix Inc |
Director |
– • – |
2013-04-09 |
4 |
B |
$0.52 |
$16,388 |
D/D |
31,515 |
6,825,000 |
2.39 |
- |
|
| CMXI |
Cytomedix Inc |
Director |
– • – |
2013-04-08 |
4 |
B |
$0.51 |
$22,177 |
D/D |
43,485 |
6,793,485 |
2.39 |
- |
|
| CMXI |
Cytomedix Inc |
Director |
– • – |
2013-02-27 |
4 |
B |
$0.53 |
$2,332 |
D/D |
4,400 |
6,750,000 |
2.31 |
- |
|
| CMXI |
Cytomedix Inc |
Director |
– • – |
2013-02-26 |
4 |
B |
$0.52 |
$10,712 |
D/D |
20,600 |
6,745,600 |
2.39 |
- |
|
| CMXI |
Cytomedix Inc |
Director |
– • – |
2013-02-22 |
4 |
B |
$0.53 |
$10,600 |
D/D |
20,000 |
6,725,000 |
2.39 |
- |
|
| CMXI |
Cytomedix Inc |
Director |
– • – |
2013-02-21 |
4 |
B |
$0.53 |
$15,900 |
D/D |
30,000 |
6,705,000 |
2.39 |
- |
|
| ACER |
Acer Therapeutics Inc |
Acting Chief Financial Officer |
• • – |
2012-12-31 |
4 |
A |
$1.33 |
$6,111 |
D/D |
4,595 |
227,094 |
0 |
- |
|
| CMXI |
Cytomedix Inc |
Director |
– • – |
2012-09-14 |
4 |
B |
$0.89 |
$22,250 |
D/D |
25,000 |
6,675,000 |
2.39 |
- |
|
| CMXI |
Cytomedix Inc |
Director |
– • – |
2012-09-11 |
4 |
B |
$0.95 |
$7,916 |
D/D |
8,333 |
6,650,000 |
2.39 |
- |
|
| CMXI |
Cytomedix Inc |
Director |
– • – |
2012-08-29 |
4 |
OE |
$1.00 |
$16,667 |
D/D |
16,667 |
6,641,667 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
